Maraviroc Tablet, Film Coated
Product Images NDC 70710-1930

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Maraviroc (NDC 70710-1930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B9cfbc86 86a5 487f 8b6d 1e9607d2f8f7 01)

Chemical structure of maraviroc, showing its molecular arrangement with labeled fluorine, nitrogen, methyl, and other groups in a complex bicyclic framework.*

FDA Label Image

Pdp-150mg (B9cfbc86 86a5 487f 8b6d 1e9607d2f8f7 02)

Label for Maraviroc 150 mg tablets, film-coated, oral dosage form by Zydus Pharmaceuticals USA Inc. The label specifies storage instructions, safety seal warning, dispensing container instructions, and states each tablet contains 150 mg of maraviroc. The package contains 60 tablets, marked Rx only, and indicates the product is made in India.*

FDA Label Image

Pdp-300mg (B9cfbc86 86a5 487f 8b6d 1e9607d2f8f7 03)

Maraviroc 300 mg film-coated tablets label showing storage instructions, dosage form, and quantity of 60 tablets. The label includes warnings about the safety seal, dispensing guidance, manufacturer information (Zydus Pharmaceuticals USA Inc.), and states the product is Rx only. Made in India is also noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.